Accessibility Menu
 

Veradermics

(NYSE) MANE

Current Price$56.72
Market Cap$2.38B
Since IPO (2026)+69%
5 YearN/A
1 YearN/A
1 Month+31%

Veradermics Financials at a Glance

Market Cap

$2.38B

Revenue (TTM)

$0.00

Net Income (TTM)

$27.51

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1.47 (Low)

Price

$56.72

Volume

348,490

Open

$63.81

Previous Close

$56.71

Daily Range

$56.59 - $63.82

52-Week Range

$17.00 - $69.41

MANE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veradermics

Industry

Pharmaceuticals

Employees

21

CEO

Reid Waldman, MD

Headquarters

New Haven, CT 06513, US

MANE Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-49%

Return on Assets

-45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.38B

Shares Outstanding

37.34M

Volume

348.49K

Short Interest

0.00%

Avg. Volume

454.02K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$26.78M

EBITDA

$25.90M

Operating Cash Flow

$23.69M

Capital Expenditure

$0.00

Free Cash Flow

$23.69M

Cash & ST Invst.

$53.08M

Total Debt

$0.00

Veradermics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.38B

N/A

Market Cap/Employee

$113.48M

N/A

Employees

21

N/A

Net Income

$5.66M

N/A

EBITDA

$5.37M

N/A

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$15.12M

N/A

Accounts Receivable

$1.23M

N/A

Inventory

$0.00

N/A

Long Term Debt

$16.00K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-44.61%

N/A

Return on Invested Capital

-48.99%

N/A

Free Cash Flow

$3.63M

N/A

Operating Cash Flow

$3.63M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TVTXTravere Therapeutics, Inc.
$31.67-0.50%
OVIDOvid Therapeutics Inc.
$2.56+11.30%
ABEOAbeona Therapeutics Inc.
$4.81+1.05%
HELPCybin Inc. Common Stock
$5.25-0.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.49-0.03%
INTCIntel
$52.91+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.15+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.25-0.01%

Questions About MANE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.